Table 3.

Treatment Outcomes for All Patients

Variable	No. of Patients	3-Year EFS		5-Year EFS		P	3-Year OS		5-Year OS		P	3-Year LC		5-Year LC		P
		%	95% CI	%	95% CI		%	95% CI	%	95% CI		%	95% CI	%	95% CI
All patients	57	73	59 to 83	69	54 to 81		81	67 to 89	78	63 to 87		81	68 to 90	81	68 to 90
Stage						.06					.02					.19
1 to 2	32	81	62 to 91	81	62 to 91		93	76 to 98	88	66 to 96		87	69 to 95	87	69 to 95
3 to 4	25	63	41 to 79	55	31 to 74		64	40 to 81	64	40 to 81		73	49 to 87	73	49 to 87
Group						.83					.65					.70
I to II	8	73	28 to 93	73	28 to 93		88	39 to 98	88	39 to 98		83	27 to 97	83	27 to 97
III to IV	49	73	58 to 83	69	53 to 81		80	65 to 89	76	60 to 87		81	67 to 90	81	67 to 90
Site (1)						.32					.19					.79
Favorable	19	79	54 to 92	79	54 to 92		89	64 to 97	89	64 to 97		79	54 to 92	79	54 to 92
Unfavorable	38	70	52 to 82	64	45 to 79		76	58 to 88	71	51 to 84		83	65 to 92	83	65 to 92
Site (2)						.55					.54					.31
Orbit	13	92	57 to 99	92	57 to 99		100	100 to 100	100	100 to 100		92	57 to 99	92	57 to 99
Parameningeal	27	66	45 to 81	60	37 to 77		76	53 to 88	69	45 to 85		77	56 to 89	77	56 to 89
Head and neck	4	50	6 to 84	50	6 to 84		75	13 to 96	75	13 to 96		50	6 to 84	50	6 to 84
Bladder and/or prostate	5	80	20 to 97	80	20 to 97		80	20 to 97	80	20 to 97		100	100 to 100	100	100 to 100
GI/genitourinary	3	67	5 to 95	67	5 to 95		67	5 to 95	67	5 to 95		67	5 to 95	67	5 to 95
Trunk/extremities	5	80	20 to 97	80	20 to 97		80	20 to 97	80	20 to 97		100	100 to 100	100	100 to 100
Histology						.32					.39					.97
Embryonal/botryoid	41	70	54 to 82	65	47 to 79		78	61 to 89	74	55 to 86		82	66 to 91	82	66 to 91
Alveolar/undifferentiated	16	81	51 to 93	81	51 to 93		87	57 to 97	87	57 to 98		81	51 to 93	81	51 to 93
Risk group						.04					.04					.20
Low	15	93	61 to 99	93	61 to 99		100	100 to 100	100	100 to 100		93	61 to 99	93	61 to 99
Intermediate	42	66	49 to 78	61	43 to 75		74	57 to 85	70	52 to 83		77	60 to 87	77	60 to 87
Age, years						.60					.91					.07
2-10	43	77	61 to 87	72	53 to 84		83	68 to 92	79	61 to 89		88	74 to 95	88	74 to 95
< 2 and > 10	14	64	34 to 83	64	34 to 83		76	42 to 92	76	42 to 92		64	34 to 83	64	34 to 83
Size, cm						.19					.14					.28
≤ 5	36	77	60 to 88	77	60 to 88		89	72 to 96	84	64 to 93		86	69 to 94	86	69 to 94
> 5	21	65	41 to 82	56	29 to 76		66	38 to 84	66	38 to 84		74	47 to 88	74	47 to 88

Abbreviations: EFS, event-free survival; LC, local control; OS, overall survival.